AI assistant
Gland Pharma Limited — Call Transcript 2024
Jan 18, 2024
59319_rns_2024-01-18_bcd54058-f5bd-4cf4-a85e-7943f83894c9.pdf
Call Transcript
Open in viewerOpens in your device viewer
==> picture [59 x 48] intentionally omitted <==
==> picture [298 x 20] intentionally omitted <==
January 18, 2024
BSE Limited Corporate Relationship Department Phiroze Jeejeebhoy Towers 25[th] floor, Dalal Street Mumbai - 400 001 Scrip Code: 543245
National Stock Exchange of India Limited Listing Department Exchange Plaza, 5th floor Plot no. C-1, Block G, Bandra Kurla Complex Bandra (East), Mumbai - 400 051 Symbol: GLAND (ISIN: INE068V01023)
Dear Sir/Madam,
Sub: Earnings Conference Call
In continuation to our earlier disclosure dated January 11, 2024; this is to inform that the Earnings Call for Investors/Analysts will be held on Wednesday , February 14, 2024 at 18:30 hours (IST) for 60 minutes to discuss the Company's financial performance and business updates for the quarter and nine months ended December 31, 2023.
The details of the Earnings Call for Investors/Analysts are enclosed.
The transcript and the audio recording of the Earnings Call will be made available on the Company’s website.
This is for your information and records.
Yours truly, For Gland Pharma Limited
KUMAR Digitally signed by KUMAR PALLERLAMUDI PALLERLAMU SAMPATH Date: 2024.01.18 DI SAMPATH 12:26:48 +05'30' Sampath Kumar Pallerlamudi Company Secretary and Compliance Officer
Encl: As above
==> picture [580 x 78] intentionally omitted <==
==> picture [69 x 51] intentionally omitted <==
EARNINGS CONFERENCE CALL
The Company will host Earnings conference call for the third quarter of the Financial Year 2024 on February 14[th] 2024, at 18:30 hours (IST) , during which the management team will discuss the performance and take questions. Audio record and Transcript of the conference call will be available at www.glandpharma.com.
| Earnings Conference Dial-In Information | Earnings Conference Dial-In Information |
|---|---|
| Diamond pass link | Click**here** to register |
| Universal Access | +91 22 6280 1516+91 22 7115 8875 |
| National Toll Free | 1 800 120 1221 |
| International Toll-Free Number | USA – 18667462133UK – 08081011573Singapore – 8001012045HongKong– 800964448 |
Contact:
Mr. Sampath Kumar Pallerlamudi Mr. Ankit Gupta Company Secretary and Compliance Officer Head – Investments, Strategy & Investor Relations [email protected] [email protected]